JP2016523276A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016523276A5 JP2016523276A5 JP2016522457A JP2016522457A JP2016523276A5 JP 2016523276 A5 JP2016523276 A5 JP 2016523276A5 JP 2016522457 A JP2016522457 A JP 2016522457A JP 2016522457 A JP2016522457 A JP 2016522457A JP 2016523276 A5 JP2016523276 A5 JP 2016523276A5
- Authority
- JP
- Japan
- Prior art keywords
- dichlorophenyl
- pyrazol
- yloxy
- substituted
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13382246.0 | 2013-06-26 | ||
| EP13382246.0A EP2818166A1 (en) | 2013-06-26 | 2013-06-26 | Use of sigma receptor ligands for the prevention and treatment of pain associated to interstitial cystitis/bladder pain syndrome (IC/BPS) |
| PCT/EP2014/063360 WO2014207024A1 (en) | 2013-06-26 | 2014-06-25 | Use of sigma receptor ligands for the prevention and treatment of pain associated to interstitial cystitis/bladder pain syndrome (ic/bps) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016523276A JP2016523276A (ja) | 2016-08-08 |
| JP2016523276A5 true JP2016523276A5 (enExample) | 2017-08-03 |
Family
ID=48700506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016522457A Pending JP2016523276A (ja) | 2013-06-26 | 2014-06-25 | 間質性膀胱炎／膀胱痛症候群（ｉｃ／ｂｐｓ）に関連する疼痛の予防および治療のためのシグマリガンドの使用 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20160151377A1 (enExample) |
| EP (2) | EP2818166A1 (enExample) |
| JP (1) | JP2016523276A (enExample) |
| KR (1) | KR20160023839A (enExample) |
| CN (1) | CN105377257A (enExample) |
| AR (1) | AR096709A1 (enExample) |
| AU (1) | AU2014301220A1 (enExample) |
| BR (1) | BR112015032343A8 (enExample) |
| CA (1) | CA2916568A1 (enExample) |
| HK (1) | HK1221656A1 (enExample) |
| IL (1) | IL243362A0 (enExample) |
| MA (1) | MA38711A1 (enExample) |
| MX (1) | MX2015017761A (enExample) |
| PH (1) | PH12015502815A1 (enExample) |
| RU (1) | RU2016102149A (enExample) |
| SG (1) | SG11201510408XA (enExample) |
| TN (1) | TN2015000558A1 (enExample) |
| TW (1) | TWI629984B (enExample) |
| WO (1) | WO2014207024A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2116539A1 (en) | 2008-04-25 | 2009-11-11 | Laboratorios Del. Dr. Esteve, S.A. | 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof |
| EP2353598A1 (en) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for use in the prevention and/or treatment of postoperative pain |
| EP2353591A1 (en) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof |
| EP2388005A1 (en) | 2010-05-21 | 2011-11-23 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy |
| EP2415471A1 (en) | 2010-08-03 | 2012-02-08 | Laboratorios Del. Dr. Esteve, S.A. | Use of sigma ligands in opioid-induced hyperalgesia |
| EP2524694A1 (en) | 2011-05-19 | 2012-11-21 | Laboratorios Del. Dr. Esteve, S.A. | Use of sigma ligands in diabetes type-2 associated pain |
| SG11201604478UA (en) * | 2013-12-17 | 2016-07-28 | Esteve Labor Dr | Gabapentinoids and sigma receptor ligands combinations |
| SG11201604480PA (en) | 2013-12-17 | 2016-07-28 | Esteve Labor Dr | SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIs) AND SIGMA RECEPTOR LIGANDS COMBINATIONS |
| US11034669B2 (en) | 2018-11-30 | 2021-06-15 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
| KR20250116520A (ko) | 2024-01-25 | 2025-08-01 | 가톨릭대학교 산학협력단 | 칸나비디올을 유효성분으로 포함하는 방광 통증 증후군의 예방 또는 치료용 조성물 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL208138B1 (pl) * | 2001-07-10 | 2011-03-31 | Astellas Pharma Inc | Zastosowanie kompozycji farmaceutycznej |
| AU2005276590B2 (en) | 2004-08-27 | 2011-05-19 | Laboratorios Del Dr. Esteve, S.A. | Sigma receptor inhibitors |
| TWI356699B (en) * | 2004-11-10 | 2012-01-21 | Kissei Pharmaceutical | Agent for treating interstitial cystitis and agent |
| US20090325975A1 (en) * | 2005-07-15 | 2009-12-31 | Helmut H Buschmann | Use of compounds binding to the sigma receptor for the treatment of diabetes-associated pain |
| JP2009528315A (ja) * | 2006-03-01 | 2009-08-06 | ラボラトリオス・デル・ドクトル・エステベ・ソシエダッド・アノニマ | シグマ受容体阻害剤としてのピラゾール誘導体 |
| CN101395157A (zh) * | 2006-03-01 | 2009-03-25 | 伊斯特芬博士实验室有限公司 | 作为西格玛受体抑制剂的吡唑衍生物 |
| EP2113501A1 (en) * | 2008-04-25 | 2009-11-04 | Laboratorios Del. Dr. Esteve, S.A. | 5-Methyl-1-(naphthalen-2-YL)-1H-Pyrazoles useful as sigma receptor inhibitors |
| EP2116539A1 (en) * | 2008-04-25 | 2009-11-11 | Laboratorios Del. Dr. Esteve, S.A. | 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof |
| EP2353591A1 (en) * | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof |
| EP2353598A1 (en) * | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for use in the prevention and/or treatment of postoperative pain |
| EP2460804A1 (en) * | 2010-12-03 | 2012-06-06 | Laboratorios Del Dr. Esteve, S.A. | 5-methyl-1-(naphthalen-2-yl)-1h-pyrazole derivatives and their use in potentiating the effect of opioid analgesics |
| EP2460519A1 (en) * | 2010-12-03 | 2012-06-06 | Laboratorios Del. Dr. Esteve, S.A. | Use of sigma ligands in bone cancer pain |
| SI2712358T1 (sl) * | 2011-05-13 | 2017-03-31 | Array Biopharma, Inc. | Spojine pirolidinil sečnine, pirolidinil tiosečnine in pirolidinil gvanidina kot inhibitorji kinaze trka |
| EP2524694A1 (en) * | 2011-05-19 | 2012-11-21 | Laboratorios Del. Dr. Esteve, S.A. | Use of sigma ligands in diabetes type-2 associated pain |
-
2013
- 2013-06-26 EP EP13382246.0A patent/EP2818166A1/en not_active Withdrawn
-
2014
- 2014-06-24 AR ARP140102374A patent/AR096709A1/es unknown
- 2014-06-24 TW TW103121723A patent/TWI629984B/zh not_active IP Right Cessation
- 2014-06-25 KR KR1020167001865A patent/KR20160023839A/ko not_active Withdrawn
- 2014-06-25 AU AU2014301220A patent/AU2014301220A1/en not_active Abandoned
- 2014-06-25 JP JP2016522457A patent/JP2016523276A/ja active Pending
- 2014-06-25 CN CN201480040098.1A patent/CN105377257A/zh active Pending
- 2014-06-25 EP EP14734099.6A patent/EP3013338A1/en not_active Withdrawn
- 2014-06-25 TN TN2015000558A patent/TN2015000558A1/en unknown
- 2014-06-25 MA MA38711A patent/MA38711A1/fr unknown
- 2014-06-25 SG SG11201510408XA patent/SG11201510408XA/en unknown
- 2014-06-25 RU RU2016102149A patent/RU2016102149A/ru not_active Application Discontinuation
- 2014-06-25 WO PCT/EP2014/063360 patent/WO2014207024A1/en not_active Ceased
- 2014-06-25 CA CA2916568A patent/CA2916568A1/en not_active Abandoned
- 2014-06-25 BR BR112015032343A patent/BR112015032343A8/pt not_active Application Discontinuation
- 2014-06-25 US US14/900,786 patent/US20160151377A1/en not_active Abandoned
- 2014-06-25 HK HK16109869.1A patent/HK1221656A1/zh unknown
- 2014-06-25 MX MX2015017761A patent/MX2015017761A/es unknown
-
2015
- 2015-12-17 PH PH12015502815A patent/PH12015502815A1/en unknown
- 2015-12-27 IL IL243362A patent/IL243362A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016523276A5 (enExample) | ||
| JP2014501732A5 (enExample) | ||
| JP2013532709A5 (enExample) | ||
| JP2017503765A5 (enExample) | ||
| JP2013529206A5 (enExample) | ||
| JP2011518807A5 (enExample) | ||
| RU2013130222A (ru) | Применение сигма-лигандов от боли при раке костей | |
| RU2013109291A (ru) | Применение сигма-лигандов при индуцированной опиоидами гипералгезии | |
| RU2016102149A (ru) | Применение сигма-лигандов для предотвращения и лечения боли, связанной с интерстициальным циститом/синдромом раздраженного мочевого пузыря (иц/срмп) | |
| JP2016530322A5 (enExample) | ||
| JP2014518869A5 (enExample) | ||
| RU2013156367A (ru) | Применение сигма-лигандов при боли, связанной с диабетом 2 типа | |
| RU2012137506A (ru) | Сигма-лиганды для потенцирования анальгетического эффекта опиоидов и опиатов при послеоперационной боли и для ослабления зависимости от них | |
| JP2016540771A5 (enExample) | ||
| RU2010147925A (ru) | 1-арил-3-аминоалкоксипиразолы как сигма-лиганды, усиливающие обезболивающее действие опиоидов и ослабляющие зависимость от них | |
| JP2016516792A5 (enExample) | ||
| RU2016113713A (ru) | Комбинации nsaid и лигандов сигма-рецепторов | |
| CA2576144A1 (en) | Sigma receptor inhibitors | |
| RU2018140092A (ru) | Новые пиразолпиримидиновые производные | |
| DK2576543T3 (en) | Pyrazole compounds as sigma receptor inhibitors | |
| RU2015148766A (ru) | Комбинации лигандов альфа-2 адренорецептора и сигма рецептора | |
| JP2017525700A5 (enExample) | ||
| JP2019513776A5 (enExample) | ||
| JP2016516026A5 (enExample) | ||
| HRP20170112T1 (hr) | Supstituirani spojevi piridin-2-karboksamida kao kinazni inhibitori signalne regulacije apoptoze |